Locust Walk Acquisition Corp.

Status: Deal Closed
U=S+W/3 W=S@11.5
Target: eFFECTOR Therapeutics; Closing Date: Aug 25, 2021
IPO Proceeds, $M $175.00M
IPO Date Jan 8, 2021
CEO Chris Ehrlich
Left Lead Cantor Fitzgerald
IPO Cash in Trust 100.0%
SPAC Tenor 24 months
IPO Sector Healthcare

Healthcare in the United States and Europe

IPO Geography Global
Target Company eFFECTOR Therapeutics
Deal Announced May 27, 2021
Deal Size, $M $419.00M
Deal Geography US/Canada
Deal Sector Healthcare
SEC Filings
Closing Date Aug 25, 2021

Sign up for Free Trial

No credit card required

Sign in for more data on Locust Walk Acquisition Corp.:

  • 8 directors & officers
  • 14 filings and events
  • 1 underwriters
  • 7 deal advisors
  • 2 legal advisors
  • 153 shareholders (from 13F filings)